ENDRA Life Sciences (NDRA) executive Thornton bought 15,000 shares for $24.8K at $1.65
Insider transactions reported
Michael Milos Thornton (executive at ENDRA Life Sciences Inc., NDRA) reported that they bought 15,000 shares for $24.8K at $1.65 on May 18, 2023. After these transactions the filing shows 34,139 shares held directly.
- Reporting person
- Thornton Michael Milos
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| May 18, 2023 | Open-market purchase (P) | Common Stock | +15,000 | $1.65 | $24.8K | 34,139 direct |
Holdings before and after
- Common Stock: 19,139 to 34,139 direct
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Thornton report in this NDRA Form 4?
Michael Milos Thornton (executive at ENDRA Life Sciences Inc., NDRA) reported that they bought 15,000 shares for $24.8K at $1.65 on May 18, 2023. After these transactions the filing shows 34,139 shares held directly.
How many NDRA shares does Thornton hold after this filing?
The filing shows 34,139 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for NDRA
Earlier insider filings at NDRA
- May 3, 2023SEC Form 4 filed by Digiandomenico Anthony
- Feb 2, 2023SEC Form 4 filed by Basenese Lou
- Feb 2, 2023SEC Form 4 filed by Tokman Alexander Y
- Feb 2, 2023SEC Form 4 filed by Digiandomenico Anthony
- Feb 2, 2023SEC Form 4 filed by Pestrikova Irina
Keep researching NDRA
- NDRA insider tradesEvery buy and sale reported by ENDRA Life Sciences Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- NDRA financial statementsRevenue, profit, cash flow and balance sheet from ENDRA Life Sciences Inc.'s SEC filings.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2017
Follow NDRA and get a push notification the moment its next story breaks.